These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15971198)

  • 41. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
    Lizogub VG; Riley DS; Heger M
    Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
    Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Symptom burden: multiple symptoms and their impact as patient-reported outcomes.
    Cleeland CS
    J Natl Cancer Inst Monogr; 2007; (37):16-21. PubMed ID: 17951226
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A pilot study of moderate-intensity aerobic exercise for obsessive compulsive disorder.
    Brown RA; Abrantes AM; Strong DR; Mancebo MC; Menard J; Rasmussen SA; Greenberg BD
    J Nerv Ment Dis; 2007 Jun; 195(6):514-20. PubMed ID: 17568300
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Massage therapy for symptom control: outcome study at a major cancer center.
    Cassileth BR; Vickers AJ
    J Pain Symptom Manage; 2004 Sep; 28(3):244-9. PubMed ID: 15336336
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular mechanisms in cytotoxic drug induced fatigue.
    Hartvig Honoré P
    Ann Pharm Fr; 2010 Mar; 68(2):76-81. PubMed ID: 20434596
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changes in children's reports of symptom occurrence and severity during a course of myelosuppressive chemotherapy.
    Baggott C; Dodd M; Kennedy C; Marina N; Matthay KK; Cooper BA; Miaskowski C
    J Pediatr Oncol Nurs; 2010; 27(6):307-15. PubMed ID: 20739586
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Testing the differential effects of symptom management interventions in cancer.
    Sikorskii A; Given CW; Siddiqi AE; Champion V; McCorkle R; Spoelstra SL; Given BA
    Psychooncology; 2015 Jan; 24(1):25-32. PubMed ID: 24737669
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment with oral anticancer agents: symptom severity and attribution, and interference with comorbidity management.
    Spoelstra SL; Given CW; Sikorskii A; Majumder A; Schueller M; Given BA
    Oncol Nurs Forum; 2015 Jan; 42(1):80-8. PubMed ID: 25490974
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Benefits of using a chemotherapy symptom assessment scale.
    Dikken C
    Nurs Times; 2003 Sep 30-Oct 6; 99(39):50-1. PubMed ID: 14562665
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Symptom management for cancer patients: a trial comparing two multimodal interventions.
    Sikorskii A; Given CW; Given B; Jeon S; Decker V; Decker D; Champion V; McCorkle R
    J Pain Symptom Manage; 2007 Sep; 34(3):253-64. PubMed ID: 17618080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Candidemia in patients with cancer: are persistent neutropenia and severity of illness score still relevant?
    Nucci M; Anaissie E
    Clin Infect Dis; 2005 Apr; 40(7):1063-4; author reply 1064-7. PubMed ID: 15825006
    [No Abstract]   [Full Text] [Related]  

  • 53. Reducing symptom limitations: a cognitive behavioral intervention randomized trial.
    Doorenbos A; Given B; Given C; Verbitsky N; Cimprich B; McCorkle R
    Psychooncology; 2005 Jul; 14(7):574-84. PubMed ID: 15643674
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Response analysis for multiple symptoms revealed differences between arms of a symptom management trial.
    Sikorskii A; Given CW; You M; Jeon S; Given BA
    J Clin Epidemiol; 2009 Jul; 62(7):716-24. PubMed ID: 19124223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Establishing mild, moderate, and severe scores for cancer-related symptoms: how consistent and clinically meaningful are interference-based severity cut-points?
    Given B; Given CW; Sikorskii A; Jeon S; McCorkle R; Champion V; Decker D
    J Pain Symptom Manage; 2008 Feb; 35(2):126-35. PubMed ID: 18158231
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of warm salt water foot bath on the management of chemotherapy-induced fatigue.
    Akyuz Ozdemir F; Can G
    Eur J Oncol Nurs; 2021 Jun; 52():101954. PubMed ID: 33864994
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prediction of morning fatigue severity in outpatients receiving chemotherapy: less may still be more.
    Kober KM; Roy R; Conley Y; Dhruva A; Hammer MJ; Levine J; Olshen A; Miaskowski C
    Support Care Cancer; 2023 Apr; 31(5):253. PubMed ID: 37039882
    [TBL] [Abstract][Full Text] [Related]  

  • 58. White cells count.
    Martell R
    Nurs Stand; 2003 Nov 26-Dec 2; 18(11):18. PubMed ID: 14689659
    [No Abstract]   [Full Text] [Related]  

  • 59. Foreword.
    Delman KA
    Curr Probl Cancer; 2015; 39(5):273. PubMed ID: 26278380
    [No Abstract]   [Full Text] [Related]  

  • 60. A proposal for a simplified MASCC score.
    Wierema JC; Links M
    Support Care Cancer; 2013 Apr; 21(4):915-6. PubMed ID: 23247772
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.